Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

PTH vs PJP overlap: 22% of top holdings shared

Bottom line

How much do PTH and PJP overlap?

22% of their top holdings overlap by weight. 6 securities appear in both funds' top 25, making up 36.5% of PTH's assets and 24.2% of PJP's. They are substantially different portfolios, so owning both adds real diversification.

Updated Nov 22, 2026

Overlap at a glance

PTHPJP
Weight overlap (top 25)22%
Shared holdings6
Weight in shared holdings36.5%24.2%
Total positions5733
Expense ratio0.6%0.58%
Holdings as ofJul 31, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Holdings PTH and PJP have in common

Holding% of PTH% of PJPOverlap
Invesco Private Prime Fund20.79%7.93%7.93%
Invesco Private Government Fund6.84%3.73%3.73%
Liquidia Corp.3.01%3.66%3.01%
Travere Therapeutics, Inc.2.16%3.30%2.16%
Jazz Pharmaceuticals PLC1.93%2.79%1.93%
Viatris Inc.1.82%2.83%1.82%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in PTH

  1. Guardant Health, Inc. — 4.97%
  2. Roivant Sciences Ltd. — 4.95%
  3. Revolution Medicines, Inc. — 4.94%
  4. Axsome Therapeutics, Inc. — 4.12%
  5. BrightSpring Health Services, Inc. — 4.03%
  6. Erasca, Inc. — 2.94%
  7. Oruka Therapeutics, Inc. — 2.74%
  8. 10x Genomics, Inc. — 2.27%
  9. Relay Therapeutics, Inc. — 2.25%
  10. Tango Therapeutics Inc. — 2.16%
  11. Oscar Health, Inc. — 2.10%
  12. Illumina, Inc. — 2.08%
  13. agilon health, Inc. — 2.07%
  14. Axogen, Inc. — 2.06%
  15. Arrowhead Pharmaceuticals, Inc. — 2.01%

Only in PJP

  1. Abbott Laboratories — 5.67%
  2. AbbVie Inc. — 5.48%
  3. Amgen Inc. — 5.33%
  4. Johnson & Johnson — 5.18%
  5. Merck & Co., Inc. — 5.06%
  6. Eli Lilly and Co. — 5.02%
  7. Corcept Therapeutics Inc. — 4.96%
  8. Gilead Sciences, Inc. — 4.53%
  9. Pfizer Inc. — 4.50%
  10. Amneal Pharmaceuticals, Inc. — 3.75%
  11. Ligand Pharmaceuticals Inc. — 3.20%
  12. Regeneron Pharmaceuticals, Inc. — 3.14%
  13. Harmony Biosciences Holdings, Inc. — 3.06%
  14. Bristol-Myers Squibb Co. — 2.94%
  15. Biogen Inc. — 2.75%

Asset mix

Asset typePTHPJP
Stocks100.0%99.9%
Cash & short-term funds27.7%11.8%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Country mix

CountryPTHPJP
US116.1%106.5%
IE3.0%5.2%
BM5.0%—
VG1.5%—
NL1.5%—
JE0.6%—

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do PTH and PJP overlap?
About 22% by weight. 6 securities appear in both funds' top 25 holdings; they make up 36.5% of PTH's assets and 24.2% of PJP's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do PTH and PJP have in common?
The largest shared holdings are Invesco Private Prime Fund, Invesco Private Government Fund, Liquidia Corp., Travere Therapeutics, Inc., Jazz Pharmaceuticals PLC.
Should I own both PTH and PJP?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, PTH or PJP?
PTH is broader, with 57 positions versus 33 for PJP. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.